This Week’s Healthtech Combats and Collabs!

Sep 24th 2024

Hi! This is where health and tech intersect!

In today’s newsletter, we are talking healthtech combats and collabs! While Particle Health launches a lawsuit against Epic, Cornerstone AI and Nvidia shoot for the stars in the healthtech arena!

In today’s healthtech in a nutshell:

  1. Particle vs. Epic: Challenging a Data Monopoly in Healthcare Innovation

  2. Cornerstone AI x Komodo Health Collaboration

  3. NVIDIA-Powered Federated Learning in Cancer Diagnosis

  4. 5 other headline hits for your perusal

The summary:

Particle Health has initiated an antitrust lawsuit against Epic Systems, alleging that Epic exploits its monopolistic power to restrict competition in the healthcare data exchange market. The lawsuit claims that Epic's practices impede smaller companies' access to critical health data, negatively impacting innovation and patient care.

Key points:

  • Allegations of Monopolistic Behavior: Particle Health accuses Epic of leveraging its dominant position in the healthcare industry to control access to health data. The lawsuit contends that Epic's practices create barriers for smaller technology firms, limiting their ability to compete and innovate in the data exchange space.

  • Impact on Innovation and Competition: The lawsuit asserts that Epic’s tactics suppress the development of new technologies and solutions that could enhance healthcare data interoperability. By restricting data access, Epic effectively stifles competition, preventing smaller companies from introducing innovations that could benefit the healthcare system.

  • Consequences for Patient Care: The complaint highlights that limited access to comprehensive health data can hinder effective healthcare delivery. This situation potentially compromises patient outcomes, as providers require robust data sharing to make informed decisions about treatment and care coordination.

Why this matters:

If Particle Health's lawsuit is successful, it could lead to increased competition in the market, allowing smaller companies to develop and implement innovative solutions that enhance patient care and data interoperability. This case also raises significant questions about the responsibilities of dominant players like Epic in ensuring fair access to health data, which is essential for advancing healthcare technology and improving patient outcomes. The outcome could influence how health data is shared and utilized across the industry.

The summary:

Cornerstone AI has partnered with Komodo Health, a company building data solutions for patient journey insights, to integrate its advanced data cleaning software into Komodo's MapEnhance platform. This collaboration follows a successful pilot program where Cornerstone’s algorithms improved the accuracy of Komodo’s Lab Results, enhancing the preparation and analysis of clinical data.

Key points:

  • Integration of AI Solutions: Cornerstone AI’s software is designed to clean and prepare healthcare data faster and more accurately by using self-learning algorithms to structure and correct inconsistencies, fill gaps, and ensure a complete audit trail.

  • Enhanced Data Quality: The integration strengthens Komodo Health’s Lab Results product by improving the fidelity of lab insights through enhanced data standardization, enabling better analytics for clinical trial design, drug safety monitoring, and identifying new drug opportunities.

  • Comprehensive Insights with MapEnhance: The partnership enriches Komodo’s MapEnhance platform, which offers a wide range of healthcare insights, including lab results, genomics, and electronic health records, thereby supporting deeper longitudinal research across various disease categories.

Why this matters:

This collaboration represents a significant advancement in healthcare data management, as improved data quality is critical for accurate analyses and better patient outcomes. By enhancing the standardization and cleanliness of clinical data, this partnership enables healthcare providers and researchers to derive more reliable insights, ultimately leading to more informed decision-making in clinical trials and drug development.

The summary:

A collaborative team from top U.S. medical centers is harnessing NVIDIA-powered federated learning to enhance AI models for tumor segmentation, focusing on renal cell carcinoma. This innovative approach allows institutions to collaborate on AI development without compromising patient data privacy, paving the way for advancements in medical imaging.

Key points:

  • Powers of Federated Learning: Federated learning allows multiple organizations to train AI models on decentralized data, tackling the common challenges of data sharing in healthcare. By keeping sensitive patient information secure, this method enables the development of robust AI models while sidestepping the complex web of privacy concerns and data management hurdles.

  • Collaborative Research Efforts: Led by the Society for Imaging Informatics and Medicine (SIIM) Machine Learning Tools and Research Subcommittee, this project integrates NVIDIA FLARE (NVFlare) and powerful RTX A5000 GPUs. Six medical centers are contributing data from around 50 imaging studies each, ensuring a diverse dataset that enhances the model's generalizability and accuracy.

  • AI-Assisted Annotation for Improved Performance: The initial phase of the project focuses on manually labeling training data, with plans to transition to AI-assisted annotation using NVIDIA MONAI. This phase aims to evaluate whether AI-segmented data can improve overall annotation accuracy.

Why this matters:

This initiative is a game-changer in overcoming the data privacy challenges that often stifle innovation in healthcare. By utilizing federated learning, researchers can enhance the accuracy and applicability of AI models without compromising patient confidentiality. This collaborative approach not only speeds up the development of advanced imaging tools but also promises to improve patient care through more precise diagnoses and treatment options.

Other headline hits:

  • Healthy.io, a healthtech company developing at home urine testing kits, has announced the layoff of 40 employees across the UK, U.S., and Israel. This aims to streamline operations and guide the company towards profitability, marking its second major round of layoffs this year.

  • Alan, the unicorn French health insurance startup, has raised €173 million in a Series F funding round, led by General Atlantic and with participation from existing investors. This funding will help Alan expand its product offerings and accelerate its growth in European markets.

  • Harrison.ai has launched Harrison.rad.1, a radiology-specific vision language model capable of open-ended dialogue about X-ray images, detecting findings, and generating reports. Trained on proprietary data and annotated by medical specialists, the model achieved impressive performance metrics, outscoring major AI models.

  • See-Mode Technologies has received the first 510(k) clearance from the FDA for its AI-powered software designed to detect and diagnose thyroid issues in ultrasound scans. The solution identifies and classifies nodules using the TI-RADS rating system, automates worksheet generation for radiologists, and enhances the reporting process for follow-up studies.

  • Cercle has raised $6 million in funding to advance its AI-driven health data platform focused on women's health, specifically targeting areas such as fertility and hormonal health. The investment will help enhance the platform’s features, enabling better access to personalized healthcare insights and resources tailored to women's unique health needs.

Feedback

If you have specific feedback or anything interesting you’d like to share, please let us know by replying to this email.